Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2021-08-30 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 98% confidence The document is a short announcement (527 characters) regarding a stock buyback program. It explicitly directs the reader to an attached PDF for the full details, which aligns with the 'Menu vs Meal' rule for Report Publication Announcements (RPA). While it concerns share buybacks, the document itself is an announcement of the report rather than the detailed transaction log, making RPA the most accurate classification.
2021-08-30 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 99% confidence The document explicitly discusses 'Transactions under Novozymes' stock buyback program' and details the number of shares purchased and the transaction value over several days (August 23rd to August 27th, 2021). It concludes with a summary of the accumulated purchases under the program. This content directly relates to the company repurchasing its own shares. According to the definitions, this aligns perfectly with the 'Transaction in Own Shares' category (Code: POS). Although it is a detailed report, it is not a general regulatory filing (RNS) or a report publication announcement (RPA) because it contains the substantive data itself, not just an announcement that data exists elsewhere.
2021-08-30 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement of transactions under Novozymes' stock buyback program, including specific share purchase numbers, prices, and transaction values. It references the stock buyback program initiated earlier in the year and provides detailed trading data. There is no indication of financial statements, earnings data, or management discussion. The content is focused on the company's repurchase of its own shares, which fits the category of a report on transactions in own shares (share repurchase). The document is lengthy and detailed, not a brief announcement or a report publication notice. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2021-08-23 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (527 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled '2021_44_Stock_Buybackprogram'. This structure indicates that the current document is an announcement about the availability of a report detailing stock buyback transactions, rather than the detailed report itself. The topic is the company buying back its own shares. This aligns best with the 'Transaction in Own Shares' category (POS). However, given the 'MENU VS MEAL' rule, since this is an announcement pointing to the actual filing/details, it could also be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since POS specifically covers the *content* of share repurchases, and this document is merely announcing the availability of that content, RPA is a strong candidate if the actual details are in the linked PDF. However, POS is the most specific category for the *subject matter* (stock buyback). Given the brevity and the instruction to read the attached PDF, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it is an announcement of publication. If the content were present, it would be POS. I will select RPA as the announcement wrapper.
2021-08-23 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement of transactions under Novozymes' stock buyback program, including specific share purchase numbers, prices, and accumulated totals. It references compliance with Market Abuse Regulation and provides detailed trading data. There is no indication of financial results, earnings, management discussion, or other report types. The content is focused on the company's repurchase of its own shares, which fits the category of Transaction in Own Shares (POS). The document length is substantial and contains detailed transactional data, confirming it is not a mere announcement of a report but the actual transaction disclosure.
2021-08-16 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 99% confidence The document text is extremely short (527 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled '2021_43_Stock_Buybackprogram'. This indicates the document itself is merely an announcement about the availability of a detailed report concerning stock buybacks, rather than the detailed report itself. Stock buybacks fall under the category of the company transacting in its own shares. Therefore, the most appropriate classification is Transaction in Own Shares (POS). However, given the 'MENU VS MEAL' rule, since this is a very short announcement pointing to the full details, it could also be considered a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since POS is a specific category for the *subject matter* (share repurchase), and RPA/RNS is for the *format* (announcement of a report), I must choose the most specific category that fits the content, which is POS, unless the content is purely administrative about the release timing. Since the content *is* the subject matter (buyback transactions), POS is the primary fit, but the short length strongly suggests RPA. Given the options, POS (Transaction in Own Shares) is the subject, but the structure strongly suggests RPA (Report Publication Announcement) because it directs the user to an attachment for the actual details. I will prioritize the subject matter (POS) as the core information being conveyed, but acknowledge the RPA nature. Re-evaluating based on the rule: The document is an announcement *about* transactions in own shares. If the full details are in the PDF, this short text is an announcement of that information. POS covers the *report* of the transaction. RPA covers the *announcement* of a report. Since the text is just a pointer, RPA is technically more accurate based on the 'MENU VS MEAL' rule, but POS is the specific subject. Let's check POS definition: 'Report of the company buying back or selling its own shares (share repurchase/issuance).' This document *is* the announcement of that report. I will classify it as POS because the subject matter is highly specific, and the confidence in the subject matter outweighs the format ambiguity, although RPA is a close second. Upon final review, the content is about the buyback program itself, making POS the best fit for the subject matter, despite the short length pointing towards RPA.
2021-08-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.